GlassScriptPhysician profile
Diana Lozano
NPI 1184620247
$6,622.92
in general payments reported to CMS, 2019-2025
38 companies · $603 in 2025
The $603 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,283 · 2020: $1,142 · 2021: $1,083 · 2022: $1,041 · 2023: $837 · 2024: $634 · 2025: $603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,073.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $744.46 | 2019-2025 | |
| Glaxosmithkline, LLC. | $734.91 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Novo Nordisk INC | $626.09 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $545.20 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astellas Pharma US INC | $424.71 | 2019-2025 | Veozah |
| Amgen INC. | $380.60 | 2019-2025 | Evenity, Prolia, Krystexxa |
| Astrazeneca Pharmaceuticals LP | $347.11 | 2019-2024 | Breztri, Farxiga |
| Abbvie INC. | $266.62 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $257.45 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $232.43 | 2019-2024 | Jardiance |
| Janssen Pharmaceuticals, INC | $230.00 | 2019-2024 | Xarelto |
| Baxter Healthcare | $178.61 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $164.27 | 2021-2025 | Xifaxan |
| Merck Sharp & Dohme LLC | $154.49 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Madrigal Pharmaceuticals | $134.68 | 2025 | Rezdiffra |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $131.22 | 2023-2025 | Cologuard Collection Kit |
| Allergan, INC. | $115.07 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $113.22 | 2019 | |
| Biotronik INC. | $107.21 | 2021 | |
| Amarin Pharma, INC. | $106.02 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $86.71 | 2022-2023 | |
| Ironwood Pharmaceuticals, INC | $58.74 | 2022 | |
| Mannkind Corporation | $51.60 | 2019-2020 | |
| Abbott Laboratories | $49.80 | 2023 | Freestyle Libre |
| Genentech USA, INC. | $40.40 | 2019-2020 | |
| Inspire Medical Systems, INC. | $38.58 | 2024 | Inspire |
| Insulet Corporation | $36.64 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $36.58 | 2021-2022 | |
| Dexcom, INC. | $33.96 | 2022-2023 | Dexcom G6 Transmitter |
| Esperion Therapeutics, INC. | $28.92 | 2021 | |
| Eisai INC. | $28.71 | 2021 | |
| Sanofi Pasteur INC. | $28.30 | 2019-2020 | |
| Merz North America, INC. | $25.66 | 2022 | |
| Seqirus USA INC | $21.02 | 2025 | Flucelvax, Fluad |
| Ultragenyx Pharmaceutical INC. | $19.03 | 2020 | |
| Philips North America LLC | $16.14 | 2024 | (O58) Sleep Respiratory Care Und |
| Verona Pharma, INC. | $13.98 | 2025 | Ohtuvayre |
| Phathom Pharmaceuticals, INC. | $13.78 | 2024 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Lozano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.